59 results
Page 2 of 3
8-K
EX-99.2
5g2x7o9u
12 Sep 22
POINT Biopharma Provides Updated Efficacy and Safety Data from the Lead-In Cohort of the Phase 3 SPLASH Trial in mCRPC at ESMO Congress 2022
7:54am
S-3
EX-4.6
96o9b1n7285n
1 Jul 22
Shelf registration
4:13pm
S-3
EX-4.7
2f8h12ig
1 Jul 22
Shelf registration
4:13pm
S-3
ciuod2h
1 Jul 22
Shelf registration
4:13pm
424B3
cyizd78d14mka
13 May 22
Prospectus supplement
8:18am
424B3
mz13jq1h4ltk
31 Mar 22
Prospectus supplement
11:42am
POS AM
amgks3n4xlb0 93zxpd
25 Mar 22
Prospectus update (post-effective amendment)
8:41am
8-K
EX-99.1
f3qs56u4elt2
25 Mar 22
POINT Biopharma Reports Fiscal 2021 Financial Results and Provides Business Update
8:22am
424B3
EX-99.1
0staxsk phskqu
25 Feb 22
Prospectus supplement
8:39am
8-K
EX-99.1
aahsrhj6 hyv
25 Feb 22
Regulation FD Disclosure
8:38am
8-K
EX-99.1
sqpkklwx1iiiqy
19 Nov 21
Regulation FD Disclosure
8:09am
424B3
cg1rd nv2
12 Nov 21
Prospectus supplement
8:41am
424B3
ywlp qi45bn
13 Aug 21
Prospectus supplement
5:25pm
8-K
EX-99.1
8jygj80g x2
13 Aug 21
POINT Biopharma Reports Second Quarter 2021 Financial Results and Provides Business Update
7:00am
424B3
pzu6lr8b9ow n8kf6q
5 Aug 21
Prospectus supplement
4:26pm